Cargando…

Identification of New Prognostic Markers and Therapeutic Targets for Non-Muscle Invasive Bladder Cancer: HER2 as a Potential Target Antigen

Bacillus Calmette–Guérin (BCG) is the gold standard adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). However, given the current global shortage of BCG, new treatments are needed. We evaluated tumor microenvironment markers as potential BCG alternatives for NMIBC treatment. Programm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chae, Han Kyu, Nam, Wook, Kim, Han Gwun, Lim, Sharon, Noh, Byeong-Joo, Kim, So Won, Kang, Gil Hyun, Park, Jong Yeon, Eom, Dae-Woon, Kim, Sung Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167936/ https://www.ncbi.nlm.nih.gov/pubmed/35677058 http://dx.doi.org/10.3389/fimmu.2022.903297

Ejemplares similares

Recent Trends in Prostate Biopsy Complication Rates and the Role of Aztreonam in Periprocedural Antimicrobial Prophylaxis—A Nationwide Population-Based Study from Korea
por: Nam, Wook, et al.
Publicado: (2022)

Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma
por: Noh, Byeong-Joo, et al.
Publicado: (2020)

Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder
por: Lim, So Dug, et al.
Publicado: (2015)

Unusual Bronchopulmonary Foregut Malformation Associated with Pericardial Defect: Bronchogenic Cyst Communicating with Tubular Esophageal Duplication
por: Eom, Dae-Woon, et al.
Publicado: (2007)

Prognostic implications of immune classification using IDO1 expression in extrahepatic bile duct carcinoma
por: Noh, Byeong-Joo, et al.
Publicado: (2022)

Evaluating Antitumor Activity of Kiatomab by Targeting Cancer Stem Cell-Specific KIAA1114 Antigen in Mice
por: Kim, Sae Won, et al.
Publicado: (2019)

Androgen receptor as a prognostic biomarker and therapeutic target in uterine leiomyosarcoma
por: Baek, Min-Hyun, et al.
Publicado: (2018)

Patient-Specific Phantomless Estimation of Bone Mineral Density and Its Effects on Finite Element Analysis Results: A Feasibility Study
por: Lee, Young Han, et al.
Publicado: (2019)

Dual Targeting of EZH2 Degradation and EGFR/HER2 Inhibition for Enhanced Efficacy against Burkitt’s Lymphoma
por: Kim, Se Been, et al.
Publicado: (2023)

A chemical conjugate between HER2-targeting antibody fragment and Pseudomonas exotoxin A fragment demonstrates cytotoxic effects on HER2-expressing breast cancer cells
por: Lee, Sunju, et al.
Publicado: (2019)

Association of perioperative serum carcinoembryonic antigen level and recurrence in low-risk stage IIA colon cancer
por: Kim, Han-Gil, et al.
Publicado: (2021)

Induction of targeted necrosis with HER2-targeted platinum(iv) anticancer prodrugs
por: Wong, Daniel Yuan Qiang, et al.
Publicado: (2015)

Improved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome
por: Kim, Aram, et al.
Publicado: (2017)

miR-526b targets 3′ UTR of MMP1 mRNA
por: Kim, Kyu-Han, et al.
Publicado: (2015)

HER2 as a novel therapeutic target for cervical cancer
por: Oh, Doo-Yi, et al.
Publicado: (2015)

Carcinoembryonic Antigen Level Can be Overestimated in Metabolic Syndrome
por: Kim, Kyu-Nam, et al.
Publicado: (2011)

Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer
por: Chen, Dong, et al.
Publicado: (2021)

Relationship between drug targets and drug-signature networks: a network-based genome-wide landscape
por: Lee, Chae Won, et al.
Publicado: (2023)

Perioperative HER2 targeted treatment in early stage HER2-positive breast cancer
por: Hong, Joohyun, et al.
Publicado: (2022)

Glutamine Synthetase as a Therapeutic Target for Cancer Treatment
por: Kim, Go Woon, et al.
Publicado: (2021)

Targeting HER proteins in cancer therapy and the role of the non-target HER3
por: Hsieh, A C, et al.
Publicado: (2007)

PIK3CA Mutation Is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients
por: Kim, Ju Won, et al.
Publicado: (2023)

Urethral defect due to periurethral abscess treated with a tunica vaginalis flap: A case report
por: Kim, Sung Jin, et al.
Publicado: (2018)

Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma
por: Sung, You-Na, et al.
Publicado: (2021)

Fanconi Anemia Pathway Activation by FOXM1 is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance
por: Roh, Yun-Gil, et al.
Publicado: (2020)

Novel anal sphincter saving procedure with partial excision of levator-ani muscle in rectal cancer invading ipsilateral pelvic floor
por: Noh, Gyoung Tae, et al.
Publicado: (2017)

Influence of Local Myocardial Infarction on Endothelial Function, Neointimal Progression, and Inflammation in Target and Non-Target Vascular Territories in a Porcine Model of Acute Myocardial Infarction
por: Kim, Hyun Kuk, et al.
Publicado: (2019)

Roles of Wnt Target Genes in the Journey of Cancer Stem Cells
por: Kim, Jee-Heun, et al.
Publicado: (2017)

Accurate Detection of Urothelial Bladder Cancer Using Targeted Deep Sequencing of Urine DNA
por: Lee, Dongin, et al.
Publicado: (2023)

Electrostatic interaction of tumor-targeting adenoviruses with aminoclay acquires enhanced infectivity to tumor cells inside the bladder and has better cytotoxic activity
por: Kim, Soo-Yeon, et al.
Publicado: (2017)

Targeted sequencing with enrichment PCR: a novel diagnostic method for the detection of EGFR mutations
por: Kang, Suki, et al.
Publicado: (2015)

A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer
por: Mota, Jose Mauricio, et al.
Publicado: (2017)

Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy
por: Han, Hye-Suk, et al.
Publicado: (2009)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression
por: Han, Chungyong, et al.
Publicado: (2018)

Ultrastrong Hybrid Fibers with Tunable Macromolecular Interfaces of Graphene Oxide and Carbon Nanotube for Multifunctional Applications
por: Kim, Seo Gyun, et al.
Publicado: (2022)

Second-Generation JK-206 Targets the Oncogenic Signal Mediator RHOA in Gastric Cancer
por: Beak, Myeonghun, et al.
Publicado: (2022)

Aptamer-targeted Antigen Delivery
por: Wengerter, Brian C, et al.
Publicado: (2014)

Ki67 Antigen as a Predictive Factor for Prognosis of Sinonasal Mucosal Melanoma
por: Kim, Dong-Kyu, et al.
Publicado: (2008)

Diagnostic algorithm for papillary urothelial tumors in the urinary bladder
por: Shim, Jung-Weon, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_qfp2u4hpo3t8v2bpheql66c1pe